PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
Abstract Background Advanced stage laryngeal squamous cell carcinoma (LSCC) presents a poor prognosis; thus, there is a great need to identify novel prognostic molecular markers. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) is thought to be a novel prognostic factor in several cancers,...
Main Authors: | Xiaoli Sheng, Yunxian Li, Yixuan Li, Wenlin Liu, Zhongming Lu, Jiandong Zhan, Mimi Xu, Liangsi Chen, Xiaoning Luo, Gang Cai, Siyi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-6029-y |
Similar Items
-
Regulatory Mechanisms of lncRNAs and Their Target Gene Signaling Pathways in Laryngeal Squamous Cell Carcinoma
by: Wei Li, et al.
Published: (2020-07-01) -
Expression and Prognostic Role of PLOD1 in Malignant Glioma
by: Wang H, et al.
Published: (2020-12-01) -
Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
by: Bo Yang, et al.
Published: (2020-09-01) -
Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
by: Junhong Shi, et al.
Published: (2021-09-01) -
The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
by: Lei Tian, et al.
Published: (2021-05-01)